These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 19716144)

  • 1. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls.
    Jensen CB; Storgaard H; Holst JJ; Dela F; Madsbad S; Vaag A
    Metabolism; 2005 Oct; 54(10):1398-406. PubMed ID: 16154442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose and fat utilization during intravenous administration of glucose and lipid emulsion in non-insulin-dependent diabetic patients.
    Pelikánová T; Krausová Z; Kohout M; Válek J; Basĕ J
    Nutrition; 1993; 9(1):18-22. PubMed ID: 8467106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium salicylate on oxidative stress and insulin resistance induced by free fatty acids.
    He B; Zhao S; Zhang W; Li Y; Han P
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):49-53. PubMed ID: 20133229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.
    Stingl H; Raffesberg W; Nowotny P; Waldhäusl W; Roden M
    Obes Res; 2002 Nov; 10(11):1111-9. PubMed ID: 12429874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
    Gertow K; Rosell M; Sjögren P; Eriksson P; Vessby B; de Faire U; Hamsten A; Hellenius ML; Fisher RM
    Eur J Clin Nutr; 2006 Dec; 60(12):1406-13. PubMed ID: 16788709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypertriglyceridemic clamp technique. Studies using long-chain and structured triglyceride emulsions in healthy subjects.
    Nordenström J; Thörne A; Aberg W; Carneheim C; Olivecrona T
    Metabolism; 2006 Nov; 55(11):1443-50. PubMed ID: 17046545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of short-term high-fat diet on glucose and lipid metabolism in male Han Chinese with type 2 diabetes mellitus].
    Li WH; Xiao XH; Yu K; Sun Q; Yang GH; Wang H; Ole S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):509-15. PubMed ID: 18795630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
    Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
    Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.